Inuvo, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Inuvo, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $86.21M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $83.79M | Mar 5, 2026 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $79.55M | Feb 8, 2018 |
| FY2017 | Dec 31, 2016 | $71.53M | Feb 8, 2018 |
| FY2016 | Dec 31, 2015 | $70.44M | Feb 16, 2017 |
| FY2015 | Dec 31, 2014 | $49.60M | Feb 12, 2016 |
| FY2014 | Dec 31, 2013 | $54.99M | Feb 9, 2015 |
| FY2013 | Dec 31, 2012 | $53.36M | Mar 10, 2014 |
| FY2012 | Dec 31, 2011 | $35.82M | Mar 13, 2013 |
| FY2011 | Dec 31, 2010 | $48.97M | Mar 29, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $64.21M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $71.76M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $63.43M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $45.36M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $43.90M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $36.34M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $38.82M | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | $43.41M | May 12, 2020 |
| FY2018 | Dec 31, 2017 | $42.88M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $50.17M | Feb 8, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($5.10M) | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | ($5.76M) | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | ($10.39M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($13.11M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($7.60M) | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | ($7.30M) | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | ($4.49M) | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | ($5.89M) | May 12, 2020 |
| FY2011 | Dec 31, 2011 | ($8.98M) | Mar 29, 2012 |
| FY2011 | Dec 31, 2010 | ($5.01M) | Mar 29, 2012 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.70M) | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | ($5.51M) | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | ($10.39M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($12.65M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($7.77M) | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | ($8.05M) | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | ($7.74M) | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | ($5.47M) | May 12, 2020 |
| FY2018 | Dec 31, 2017 | ($4.24M) | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | ($857.2K) | Feb 8, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $8.62M | Mar 10, 2023 |
| FY2022 | Dec 31, 2021 | $7.20M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $7.63M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $8.67M | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | $8.50M | May 12, 2020 |
| FY2018 | Dec 31, 2017 | $8.34M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $5.00M | Feb 8, 2018 |
| FY2016 | Dec 31, 2015 | $4.65M | Feb 16, 2017 |
| FY2015 | Dec 31, 2014 | $4.40M | Feb 12, 2016 |
| FY2014 | Dec 31, 2013 | $5.78M | Feb 9, 2015 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.79M) | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $229.6K | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | ($2.55M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($5.57M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($5.28M) | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | ($5.60M) | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | ($5.34M) | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | ($2.10M) | May 12, 2020 |
| FY2018 | Dec 31, 2017 | ($1.15M) | Mar 15, 2019 |
| FY2012 | Dec 31, 2012 | $990.7K | Mar 13, 2013 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.87M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $32.20M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $32.37M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $35.56M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $44.00M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $35.18M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $30.69M | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | $28.67M | May 12, 2020 |
| FY2018 | Dec 31, 2017 | $38.25M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $27.56M | Feb 8, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.02M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $13.47M | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | $16.98M | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | $21.75M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $32.81M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $25.29M | Mar 10, 2023 |
| FY2021 | Dec 31, 2019 | $14.45M | Mar 17, 2022 |
| FY2020 | Dec 31, 2018 | $12.95M | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $14.09M | May 12, 2020 |
| FY2018 | Dec 31, 2016 | $11.53M | Mar 15, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.85M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $9.85M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $9.85M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $9.85M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $9.85M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $9.85M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $9.85M | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | $9.85M | May 12, 2020 |
| FY2018 | Dec 31, 2017 | $9.85M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $5.76M | Feb 8, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($178.30M) | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | ($173.21M) | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | ($167.45M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($157.06M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($143.95M) | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | ($136.35M) | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | ($129.05M) | Feb 11, 2021 |
| FY2020 | Dec 31, 2018 | ($124.56M) | Feb 11, 2021 |
| FY2018 | Dec 31, 2017 | ($120.58M) | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | ($117.52M) | Feb 8, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $2.93M | Mar 10, 2023 |
| FY2022 | Dec 31, 2021 | $10.48M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $7.89M | Mar 17, 2022 |
| FY2018 | Dec 31, 2018 | $229.0K | Mar 15, 2019 |
| FY2018 | Dec 31, 2017 | $4.08M | Mar 15, 2019 |
| FY2018 | Dec 31, 2016 | $3.95M | Mar 15, 2019 |
| FY2017 | Dec 31, 2015 | $4.26M | Feb 8, 2018 |
| FY2016 | Dec 31, 2014 | $3.71M | Feb 16, 2017 |
| FY2015 | Dec 31, 2013 | $3.14M | Feb 12, 2016 |
| FY2014 | Dec 31, 2012 | $3.38M | Feb 9, 2015 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $0 | Feb 11, 2021 |
| FY2020 | Dec 31, 2019 | $3.38M | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | $1.86M | May 12, 2020 |
| FY2018 | Dec 31, 2017 | $4.90M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $0 | Feb 8, 2018 |
| FY2015 | Dec 31, 2015 | $0 | Feb 12, 2016 |
| FY2015 | Dec 31, 2014 | $3.63M | Feb 12, 2016 |
| FY2014 | Dec 31, 2013 | $6.14M | Feb 9, 2015 |
| FY2013 | Dec 31, 2012 | $7.82M | Mar 10, 2014 |
| FY2012 | Dec 31, 2011 | $2.91M | Mar 13, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | 0 | Mar 10, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | 0 | May 12, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Feb 8, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Feb 16, 2017 |
| FY2015 | Dec 31, 2014 | 0 | Feb 12, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Feb 9, 2015 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Feb 27, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Feb 27, 2025 |
| FY2022 | Dec 31, 2022 | 0 | Mar 10, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Feb 11, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14.70M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | 14.05M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | 137.98M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 120.14M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 118.75M | Mar 10, 2023 |
| FY2020 | Dec 31, 2020 | 52.22M | Feb 11, 2021 |
| FY2020 | Dec 31, 2019 | 51.85M | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | 32.38M | May 12, 2020 |
| FY2018 | Dec 31, 2017 | 28.62M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | 24.92M | Feb 8, 2018 |